|
| 36101497 | Comprehensive studies on building a scalable downstream process for mRNAs to enable mRNA therapeutics. | Biotechnol Prog | 2023 |
| 37835508 | Preoperative Serum Levels of PDGF-AB, PDGF-BB, TGF-α, EGF and ANG-2 in the Diagnosis of Endometrial Cancer. | Cancers (Basel) | 2023 |
| 37371669 | Influence of Muscle Mass and Strength on Bone Mineralisation with Consideration of Sclerostin Concentration. | Biomedicines | 2023 |
| 36572991 | CCNE1 and survival of patients with tubo-ovarian high-grade serous carcinoma: An Ovarian Tumor Tissue Analysis consortium study. | Cancer | 2023 |
| 34897700 | Validated biomarker assays confirm that ARID1A loss is confounded with MMR deficiency, CD8<sup>+</sup> TIL infiltration, and provides no independent prognostic value in endometriosis-associated ovarian carcinomas. | J Pathol | 2022 |
| 35478773 | Bladder cancer survival in patients with <i>NOD2</i> or <i>CDKN2A</i> variants. | Oncotarget | 2022 |
| 35395863 | Germline BRCA1 and BRCA2 mutations and the risk of bladder or kidney cancer in Poland. | Hered Cancer Clin Pract | 2022 |
| 36358155 | Synergic Effect of Phthalide Lactones and Fluconazole and Its New Analogues as a Factor Limiting the Use of Azole Drugs against Candidiasis. | Antibiotics (Basel) | 2022 |
| 34983599 | Germline HOXB13 mutation p.G84E do not confer an increased bladder or kidney cancer risk in polish population. | Hered Cancer Clin Pract | 2022 |
| 35313928 | Association of recurrent mutations in BRCA1, BRCA2, RAD51C, PALB2, and CHEK2 with the risk of borderline ovarian tumor. | Hered Cancer Clin Pract | 2022 |
| 33419761 | Design and Efficacy of a Monovalent Bispecific PD-1/CTLA4 Antibody That Enhances CTLA4 Blockade on PD-1<sup>+</sup> Activated T Cells. | Cancer Discov | 2021 |
| 33670479 | Recurrent Mutations in <i>BRCA1</i>, <i>BRCA2</i>, <i>RAD51C</i>, <i>PALB2</i> and <i>CHEK2</i> in Polish Patients with Ovarian Cancer. | Cancers (Basel) | 2021 |
| 34499690 | Survival of bladder or renal cancer in patients with CHEK2 mutations. | PLoS One | 2021 |
| 32473302 | Prognostic gene expression signature for high-grade serous ovarian cancer. | Ann Oncol | 2020 |
| 32633296 | Two ways of spin crossover in an iron(ii) coordination polymer associated with conformational changes of a bridging ligand. | Dalton Trans | 2020 |
| 32678463 | Spatiotemporal Studies of the One-Dimensional Coordination Polymer [Fe(ebtz)<sub>2</sub> (C<sub>2</sub> H<sub>5</sub> CN)<sub>2</sub> ](BF<sub>4</sub> )<sub>2</sub> : Tug of War between the Nitrile Reorientation Versus Crystal Lattice as a Tool for Tuning the Spin Crossover Properties*. | Chemistry | 2020 |
| 32554541 | Development and Validation of the Gene Expression Predictor of High-grade Serous Ovarian Carcinoma Molecular SubTYPE (PrOTYPE). | Clin Cancer Res | 2020 |
| 31239549 | A combination of the immunohistochemical markers CK7 and SATB2 is highly sensitive and specific for distinguishing primary ovarian mucinous tumors from colorectal and appendiceal metastases. | Mod Pathol | 2019 |
| 29502561 | MyD88 and TLR4 Expression in Epithelial Ovarian Cancer. | Mayo Clin Proc | 2018 |
| 29904064 | Cell entry of a host-targeting protein of oomycetes requires gp96. | Nat Commun | 2018 |
| 28720576 | Deubiquitinating Enzyme USP9X Suppresses Tumor Growth via LATS Kinase and Core Components of the Hippo Pathway. | Cancer Res | 2017 |
| 29049607 | Dose-Response Association of CD8+ Tumor-Infiltrating Lymphocytes and Survival Time in High-Grade Serous Ovarian Cancer. | JAMA Oncol | 2017 |
| 26885614 | MRTF/SRF dependent transcriptional regulation of TAZ in breast cancer cells. | Oncotarget | 2016 |
| 27836010 | Inheritance of deleterious mutations at both BRCA1 and BRCA2 in an international sample of 32,295 women. | Breast Cancer Res | 2016 |
| 25691823 | Selenium as a marker of cancer risk and of selection for control examinations in surveillance. | Contemp Oncol (Pozn) | 2015 |
| 25849179 | Association of type and location of BRCA1 and BRCA2 mutations with risk of breast and ovarian cancer. | JAMA | 2015 |
| 25018782 | Serum HE4, CA125, YKL-40, bcl-2, cathepsin-L and prediction optimal debulking surgery, response to chemotherapy in ovarian cancer. | J Ovarian Res | 2014 |
| 23535731 | Multiple independent variants at the TERT locus are associated with telomere length and risks of breast and ovarian cancer. | Nat Genet | 2013 |
| 22253144 | Ovarian cancer susceptibility alleles and risk of ovarian cancer in BRCA1 and BRCA2 mutation carriers. | Hum Mutat | 2012 |
| 23241574 | Selenium as marker for cancer risk and prevention. | Pol Przegl Chir | 2012 |
| 22576580 | Plasma micronutrients, trace elements, and breast cancer in BRCA1 mutation carriers: an exploratory study. | Cancer Causes Control | 2012 |
| 20798986 | The CYP17A1 -34T > C polymorphism and breast cancer risk in BRCA1 and BRCA2 mutation carriers. | Breast Cancer Res Treat | 2011 |
| 21966413 | Smoking related cancers and loci at chromosomes 15q25, 5p15, 6p22.1 and 6p21.33 in the Polish population. | PLoS One | 2011 |
| 19360465 | BRCA1-associated breast and ovarian cancer risks in Poland: no association with commonly studied polymorphisms. | Breast Cancer Res Treat | 2010 |
| 20842455 | CDH1 gene mutations do not contribute in hereditary diffuse gastric cancer in Poland. | Fam Cancer | 2010 |
| 17637740 | Cytotoxic drug-induced, p53-mediated upregulation of caspase-8 in tumor cells. | Oncogene | 2008 |
| 18781154 | An evaluation of the polymorphisms Ins16bp and Arg72Pro in p53 as breast cancer risk modifiers in BRCA1 and BRCA2 mutation carriers. | Br J Cancer | 2008 |
| 16773440 | Premature menopause in patients with BRCA1 gene mutation. | Breast Cancer Res Treat | 2006 |
| 20223006 | Population screening for cancer family syndromes in the west pomeranian region of poland. | Hered Cancer Clin Pract | 2006 |
| 20223005 | Low-risk Genes and Multi-organ Cancer Risk in the Polish Population. | Hered Cancer Clin Pract | 2006 |
| 15980987 | Breast cancer predisposing alleles in Poland. | Breast Cancer Res Treat | 2005 |
| 20223038 | Nuclear Pedigree Criteria for the Identification of Individuals Suspected to be at Risk of an Inherited Predisposition to Renal Cancer. | Hered Cancer Clin Pract | 2005 |
| 16140959 | Tumor necrosis factor-related apoptosis-inducing ligand-mediated proliferation of tumor cells with receptor-proximal apoptosis defects. | Cancer Res | 2005 |
| 15146557 | A high proportion of founder BRCA1 mutations in Polish breast cancer families. | Int J Cancer | 2004 |
| 16538203 | Colour Doppler ultrasound in preoperative assessment of the neck vessels in patients with tumours of the oral cavity and the neck region. | Med Sci Monit | 2004 |
| 12114495 | Germline mutations in the von Hippel-Lindau (VHL) gene in patients from Poland: disease presentation in patients with deletions of the entire VHL gene. | J Med Genet | 2002 |
| 10595252 | Clinical genetic services for familial breast cancer in Poland. | Dis Markers | 1999 |
| 9798408 | Hereditary breast cancer. | Pol J Pathol | 1998 |
| 8865851 | Losses at 3p common deletion sites in subtypes of kidney tumours: histopathological correlations. | Virchows Arch | 1996 |
| 7496735 | Abnormalities of chromosome 5q correlate with morphologic features of better prognosis in clear cell renal carcinomas. | Pol J Pathol | 1995 |